1472 results
Cusp overlap technique - How it evolved my practice?
21 Nov 2021 – From PCR London Valves 2021
Join Darren Mylotte, Derk Frank and Vincent Roolvink if you want to discover real-life practices with the Cusp Overlap technique, as well as to learn about its adoption benefits and its essentials procedural steps.
Lean TAVI: safe efficiencies and better economics
21 Nov 2021 – From PCR London Valves 2021
Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice
21 Nov 2021 – From PCR London Valves 2021
Join Raúl Moreno, Julian Widder and Mathias Wolfrum if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.
PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI, ENVISAGE TAVI AF, VKA in patients with AF after TAVI
21 Nov 2021 – From PCR London Valves 2021
In this session, find out more about the JenaValve TAVI system in patients with aortic regurgitation, get results from the GALILEO trial, review a late-breaking on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, and explore the safety and efficacy of edoxaban versus VKA in patients with AF...
TAVI: unusual complications
21 Nov 2021 – From PCR London Valves 2021
Here is an anthology of unexpected complications encountered during TAVI treatment: cardiac arrest during TAVI, ascending aortic pseudoaneurysm after TAVI, enterococcus faecalis abscess after TAVI, and much more in this PCR London Valves 2021 session.
Unfavorable access in TAVI
21 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session will enable you to appreciate an aortic valve-in-valve intervention through right subclavian access, observe a transfemoral TAVI through extremely tortuous aorta, view a challenging case of left axillary access TAVI in bicuspid aortic stenosis, and much more!
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
PCRonline @ TCT 2021 - Get the international perspective!
03 Nov 2021
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
PCR TV: Valve selection considerations for the Heart Team
11 Oct 2021
Which valve for which patient? The question is no longer just whether to choose a balloon-expandable or a self-expanding valve: low-risk indications, increasing number of TAVI procedures, and growing complexity of patients are leading the TAVI community to become more prescriptive and to take time to...
TAVI in Asia-Pacific 2021: an update
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to be updated on the state of TAVI in 2021, especially in the Asia-Pacific Region, and learn more about the essential steps of TAVI procedure in a bicuspid valve.
Cases on valvular disease
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...
Abstracts on TAVI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...
Best cases and research unveiled at AICT-Asia PCR 2021
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...
Complications: calcified LM-LAD PCI, CHIP and TAVI
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them.
TAVI procedure optimisation with the cusp overlap technique
27 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...
Addressing the challenges of small annuli patients with the Evolut Platform
27 Sep 2021 – From PCR Tokyo Valves 2021
Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...
Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology
27 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...
